Send me a link:

*Text messaging rates may apply.

 Dow Down 1.30% Nasdaq Down 1.59%

Immunomedics Inc. (IMMU)

-NasdaqGM
3.27 Down 0.15(4.39%) 2:12PM EDT - Nasdaq Real Time Price
Prev Close:3.42
Open:3.35
Bid:3.26 x 8800
Ask:3.27 x 300
1y Target Est:8.33
Beta:0.67
Next Earnings Date:N/A
Day's Range:3.24 - 3.39
52wk Range:3.04 - 7.35
Volume:350,837
Avg Vol (3m):746,228
Market Cap:273.06M
P/E (ttm):N/A
EPS (ttm):-0.38
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMMU

Comparison

Symbol% ChgMkt Cap
IMMUDown 4.39%273.06M
BIIBDown 2.50%79.32B
GSKUp 0.12%116.57B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):30.99
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-14) :-0.39
Quarterly EPS Est (Jun-14) :-0.12
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Immunomedics, Inc., a biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other serious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback